checkAd
    Startseite > Aktien > Allogene Therapeutics > Nachrichten
    Allogene Therapeutics Aktie
    3,0150
     
    USD
    +1,17 %
    +0,0350 USD
    Letzter Kurs 19:32:48 Nasdaq
    3,0100
     
    USD
    3.100 STK
    Geldkurs 19:32:38
    3,0200
     
    USD
    6.000 STK
    Briefkurs 19:32:38
    ISIN: US0197701065 · WKN: A2N6WN · SYM: ALLO · USA

    Neueste Nachrichten

    Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
    13.05.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
    13.05.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
    06.05.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
    26.04.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics Announces Q2 Investor Conference Participation
    09.04.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
    14.03.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
    12.03.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
    05.03.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
    28.02.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
    16.02.24 · globenewswire · Allogene Therapeutics
    Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
    16.01.24 · globenewswire · Allogene Therapeutics
    Aktien New York: Anleger nach US-Wirtschaftsdaten hin- und hergerissen
    05.01.24 · dpa-AFX · Ansys